LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Oncology Solutions TILT Biotherapeutics Ltd offers innovative clinical-stage oncology solutions that enhance T-cell therapies and immune checkpoint inhibitors, presenting a unique selling point in the biotechnology research market.

Lead Clinical Candidate The lead candidate, a clinical stage TNFα/IL2 armed oncolytic adenovirus (TILT-123), presents a promising sales opportunity for partnerships or collaborations in advancing cancer treatment options.

Strong Founder Expertise Founded by Pr. Akseli Hemminki, known for significant contributions in oncolytic viruses, TILT Biotherapeutics leverages top-tier expertise, enhancing credibility and attracting potential investors or partners.

Tech-Driven Approach Utilizing a range of technologies in their tech stack, including Typekit, jQuery, and Google Font API, positions TILT Biotherapeutics as a technologically advanced company, appealing to tech-savvy clients or collaborators.

Sustainable Growth Potential With ongoing Phase I clinical trials and a strong foundation, TILT Biotherapeutics demonstrates sustainable growth potential, making them an attractive prospect for investment or strategic alliances.

Similar companies to TILT Biotherapeutics Ltd

TILT Biotherapeutics Ltd Tech Stack

TILT Biotherapeutics Ltd uses 8 technology products and services including Typekit, Font Awesome, Twitter Emoji (Twemoji), and more. Explore TILT Biotherapeutics Ltd's tech stack below.

  • Typekit
    Font Scripts
  • Font Awesome
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • YouTube
    Video Players
  • Apache HTTP Server
    Web Servers

Media & News

TILT Biotherapeutics Ltd's Email Address Formats

TILT Biotherapeutics Ltd uses at least 1 format(s):
TILT Biotherapeutics Ltd Email FormatsExamplePercentage
First@tiltbio.comJohn@tiltbio.com
33%
First.Last@tiltbio.comJohn.Doe@tiltbio.com
17%
First@tiltbio.comJohn@tiltbio.com
33%
First.Last@tiltbio.comJohn.Doe@tiltbio.com
17%

Frequently Asked Questions

Where is TILT Biotherapeutics Ltd's headquarters located?

Minus sign iconPlus sign icon
TILT Biotherapeutics Ltd's main headquarters is located at Tukholmankatu 8B c/o Biomedicum 2B Helsinki, 00290 FI. The company has employees across 2 continents, including EuropeNorth America.

What is TILT Biotherapeutics Ltd's official website and social media links?

Minus sign iconPlus sign icon
TILT Biotherapeutics Ltd's official website is tiltbio.com and has social profiles on LinkedIn.

How much revenue does TILT Biotherapeutics Ltd generate?

Minus sign iconPlus sign icon
As of August 2024, TILT Biotherapeutics Ltd's annual revenue reached $3.8M.

What is TILT Biotherapeutics Ltd's SIC code NAICS code?

Minus sign iconPlus sign icon
TILT Biotherapeutics Ltd's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does TILT Biotherapeutics Ltd have currently?

Minus sign iconPlus sign icon
As of August 2024, TILT Biotherapeutics Ltd has approximately 25 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: A. H.Chief Operating Officer: A. K.Chief Medical Officer: K. V.. Explore TILT Biotherapeutics Ltd's employee directory with LeadIQ.

What industry does TILT Biotherapeutics Ltd belong to?

Minus sign iconPlus sign icon
TILT Biotherapeutics Ltd operates in the Biotechnology Research industry.

What technology does TILT Biotherapeutics Ltd use?

Minus sign iconPlus sign icon
TILT Biotherapeutics Ltd's tech stack includes TypekitFont AwesomeTwitter Emoji (Twemoji)Google Font APIjQueryPHPYouTubeApache HTTP Server.

What is TILT Biotherapeutics Ltd's email format?

Minus sign iconPlus sign icon
TILT Biotherapeutics Ltd's email format typically follows the pattern of . Find more TILT Biotherapeutics Ltd email formats with LeadIQ.

How much funding has TILT Biotherapeutics Ltd raised to date?

Minus sign iconPlus sign icon
As of August 2024, TILT Biotherapeutics Ltd has raised $2M in funding. The last funding round occurred on Feb 14, 2024 for $2M.

When was TILT Biotherapeutics Ltd founded?

Minus sign iconPlus sign icon
TILT Biotherapeutics Ltd was founded in 2013.
TILT Biotherapeutics Ltd

TILT Biotherapeutics Ltd

Biotechnology ResearchHelsinki, Finland11-50 Employees

TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. 

Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. 

TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his past findings in the lab, but more importantly in the clinic. The research conducted by TILT alone or in collaboration with some of world’s leading research groups with synergic technologies has generated very excellent results. The lead candidate is a clinical stage TNFα/IL2 armed oncolytic adenovirus (TILT-123 or Ad5/3-E2F-delta24-hTNFα-IRES-hIL2).  

Multiple Phase I clinical trials are ongoing.

For contact: BD (at) tiltbio.com

Section iconCompany Overview

Headquarters
Tukholmankatu 8B c/o Biomedicum 2B Helsinki, 00290 FI
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $2M

    TILT Biotherapeutics Ltd has raised a total of $2M of funding over 9 rounds. Their latest funding round was raised on Feb 14, 2024 in the amount of $2M.

  • $10M

    TILT Biotherapeutics Ltd's revenue is in the range of $10M

Section iconFunding & Financials

  • $2M

    TILT Biotherapeutics Ltd has raised a total of $2M of funding over 9 rounds. Their latest funding round was raised on Feb 14, 2024 in the amount of $2M.

  • $10M

    TILT Biotherapeutics Ltd's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.